RCMNY
BMY.RT

Rubric Capital Management (New York)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Rubric Capital Management (New York)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,650,000
Closed -$495K – 79
2020
Q4 		$495K Sell
1,650,000
-716,965
-30% -$1.53M 0.04% 63
2020
Q3 		$5.33M Sell
2,366,965
-2,377,730
-50% -$6.79M 0.5% 50
2020
Q2 		$17M Buy
4,744,695
+2,109,501
+80% +$7.61M 1.95% 27
2020
Q1 		$10M Buy
2,635,194
+20,777
+0.8% +$68.4K 1.58% 25
2019
Q4 		$7.87M Buy
+2,614,417
New +$6.8M 0.89% 35

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Rubric Capital Management (New York)'s BMY.RT Position: Q1 2021 in Review

Rubric Capital Management (New York) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,650,000 shares — an estimated $495K sold.

Rubric Capital Management (New York) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $17M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Rubric Capital Management (New York) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 1,650,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $495K.
  • Rubric Capital Management (New York) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Rubric Capital Management (New York)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $17M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2021, filed 14 May 2021.